Antibodies

Antibodies

Primary Antibodies

CDK2

AKT1

ERK5

CHK2

HER2

B RAF

CDK5

ERK2

MEK2

NEK9

PHKG2

Human

Mouse

Rat

Dog

Monkey

WB

IF

IHC

FC

IP

10k-ChIP

ELISA

Mouse

KO Validated Antibodies

Unconjugated

IgG1

IgG2a

IgG2b

Monoclonal

TrueMAB

Druggable Genome

Protein Kinase

Transcription Factors

Transmembrane

ES Cell Differentiation/IPS

Stem cell - Pluripotency

Protease

Phosphatase

Pathways in cancer

Prostate cancer

Progesterone-mediated oocyte maturation

MAPK signaling pathway

Neurotrophin signaling pathway

Small cell lung cancer

Cell cycle

Endometrial cancer

ErbB signaling pathway

Non-small cell lung cancer

p53 signaling pathway

Focal adhesion

Insulin signaling pathway

Oocyte meiosis

Pancreatic cancer

Acute myeloid leukemia

Chronic myeloid leukemia

Glioma

Melanoma

Renal cell carcinoma

B cell receptor signaling pathway

Bladder cancer

Chemokine signaling pathway

Colorectal cancer

Fc epsilon RI signaling pathway

Gap junction

GnRH signaling pathway

T cell receptor signaling pathway

Toll-like receptor signaling pathway

VEGF signaling pathway

mTOR signaling pathway

Fc gamma R-mediated phagocytosis

Adherens junction

Adipocytokine signaling pathway

Apoptosis

Calcium signaling pathway

Jak-STAT signaling pathway

Long-term depression

Long-term potentiation

Natural killer cell mediated cytotoxicity

Regulation of actin cytoskeleton

Thyroid cancer

Tight junction

Vascular smooth muscle contraction

Alzheimer's disease

Axon guidance

Melanogenesis

Prion diseases

Dorso-ventral axis formation

NOD-like receptor signaling pathway

TGF-beta signaling pathway

Type II diabetes mellitus

Carrier-free Antibodies

1

Yes